# Organon & Co.: filings

OGN · NYSE · CIK 1821825 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ogn.md) · [Financials](/companies/ogn/financials.md) · [Filings](/companies/ogn/filings.md) · [Insiders](/companies/ogn/insiders.md)

## Reports and events: 80 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 281, 8-K 48, 3 32, 10-Q 18, DEFA14A 13, SC 13G/A 7, UPLOAD 6, 10-K 5, DEF 14A 5, ARS 4, CORRESP 3, SC 13G 3, SCHEDULE 13G 3, SCHEDULE 13G/A 3, SD 3, 10-12B/A 2, 10-Q/A 2, 144 2, 4/A 2, S-8 2, SEC STAFF LETTER 2, 10-12B 1, 10-K/A 1, 8-K/A 1, CERT 1, DEFM14A 1, DRS 1, DRS/A 1, DRSLTR 1, PREM14A 1, SEC STAFF ACTION 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 08:17 ET | [8-K](/filings/0001104659-26-120423.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-120423 |
| 2026-10-30 | 08:03 ET | [10-Q](/filings/0001821825-26-000004.md) | Quarterly report, period 2026-09-30 | 0001821825-26-000004 |
| 2026-07-31 | 08:23 ET | [8-K](/filings/0001104659-26-089008.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-089008 |
| 2026-07-31 | 08:06 ET | [10-Q](/filings/0001628280-26-051230.md) | Quarterly report, period 2026-06-30 | 0001628280-26-051230 |
| 2026-07-23 | 17:13 ET | [8-K](/filings/0001193125-26-314587.md) | 5.07 Shareholder vote results | 0001193125-26-314587 |
| 2026-07-17 | 16:01 ET | [8-K](/filings/0001193125-26-307767.md) | 8.01 Other events | 0001193125-26-307767 |
| 2026-06-11 | 16:15 ET | [8-K](/filings/0001104659-26-072953.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-072953 |
| 2026-05-04 | 08:46 ET | [10-Q](/filings/0001628280-26-029532.md) | Quarterly report, period 2026-03-31 | 0001628280-26-029532 |
| 2026-04-30 | 07:48 ET | [8-K](/filings/0001104659-26-052165.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-052165 |
| 2026-04-27 | 06:06 ET | [8-K](/filings/0001193125-26-178718.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-178718 |
| 2026-04-24 | 16:30 ET | [DEF 14A](/filings/0001193125-26-177411.md) | Proxy statement, period 2026-06-09 | 0001193125-26-177411 |
| 2026-02-24 | 16:24 ET | [10-K](/filings/0001628280-26-011125.md) | Annual report, period 2025-12-31 | 0001628280-26-011125 |
| 2026-02-20 | 07:30 ET | [8-K](/filings/0001104659-26-017870.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-017870 |
| 2026-02-12 | 07:45 ET | [8-K](/filings/0001104659-26-013888.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-013888 |
| 2025-11-10 | 08:08 ET | [10-Q](/filings/0001628280-25-050795.md) | Quarterly report, period 2025-09-30 | 0001628280-25-050795 |
| 2025-11-10 | 07:34 ET | [8-K](/filings/0001104659-25-108821.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-108821 |
| 2025-11-10 | 06:17 ET | [10-Q/A](/filings/0001104659-25-108740.md) | Quarterly report, amended, period 2025-06-30 | 0001104659-25-108740 |
| 2025-11-10 | 06:12 ET | [10-Q/A](/filings/0001104659-25-108732.md) | Quarterly report, amended, period 2025-03-31 | 0001104659-25-108732 |
| 2025-11-10 | 06:03 ET | [10-K/A](/filings/0001104659-25-108693.md) | Annual report, amended, period 2024-12-31 | 0001104659-25-108693 |
| 2025-11-07 | 07:30 ET | [8-K](/filings/0001104659-25-108130.md) | 5.02 Departure or appointment of officers or directors | 0001104659-25-108130 |
| 2025-10-30 | 16:47 ET | [8-K/A](/filings/0001104659-25-104442.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-104442 |
| 2025-10-27 | 07:37 ET | [8-K](/filings/0001104659-25-102324.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-102324 |
| 2025-08-06 | 08:43 ET | [10-Q](/filings/0001821825-25-000066.md) | Quarterly report, period 2025-06-30 | 0001821825-25-000066 |
| 2025-08-05 | 07:44 ET | [8-K](/filings/0001104659-25-073929.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-073929 |
| 2025-06-12 | 16:20 ET | [8-K](/filings/0001104659-25-058900.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-25-058900 |
| 2025-05-27 | 16:18 ET | [8-K](/filings/0001104659-25-052994.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-052994 |
| 2025-05-02 | 08:42 ET | [10-Q](/filings/0001821825-25-000023.md) | Quarterly report, period 2025-03-31 | 0001821825-25-000023 |
| 2025-05-01 | 07:12 ET | [8-K](/filings/0001104659-25-043023.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-043023 |
| 2025-04-25 | 16:36 ET | [DEF 14A](/filings/0000950170-25-058795.md) | Proxy statement, period 2025-06-10 | 0000950170-25-058795 |
| 2025-04-15 | 17:05 ET | [8-K](/filings/0001104659-25-035173.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001104659-25-035173 |
| 2025-02-28 | 16:55 ET | [10-K](/filings/0001821825-25-000006.md) | Annual report, period 2024-12-31 | 0001821825-25-000006 |
| 2025-02-13 | 08:01 ET | [8-K](/filings/0001104659-25-012546.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-012546 |
| 2025-01-21 | 07:01 ET | [8-K](/filings/0001104659-25-004711.md) | 5.02 Departure or appointment of officers or directors | 0001104659-25-004711 |
| 2024-12-23 | 06:01 ET | [8-K](/filings/0001104659-24-130976.md) | 8.01 Other events | 0001104659-24-130976 |
| 2024-12-06 | 16:15 ET | [8-K](/filings/0001104659-24-126309.md) | 5.02 Departure or appointment of officers or directors | 0001104659-24-126309 |
| 2024-11-05 | 07:40 ET | [8-K](/filings/0001104659-24-114101.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-114101 |
| 2024-11-01 | 08:06 ET | [10-Q](/filings/0001821825-24-000108.md) | Quarterly report, period 2024-09-30 | 0001821825-24-000108 |
| 2024-10-31 | 08:00 ET | [8-K](/filings/0001104659-24-112866.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-112866 |
| 2024-09-23 | 16:21 ET | [8-K](/filings/0001104659-24-102053.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-24-102053 |
| 2024-08-07 | 08:07 ET | [10-Q](/filings/0001821825-24-000083.md) | Quarterly report, period 2024-06-30 | 0001821825-24-000083 |
| 2024-08-06 | 07:39 ET | [8-K](/filings/0001104659-24-086103.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-086103 |
| 2024-06-06 | 07:00 ET | [8-K](/filings/0001104659-24-068876.md) | 5.07 Shareholder vote results | 0001104659-24-068876 |
| 2024-05-17 | 16:15 ET | [8-K](/filings/0001104659-24-063008.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-24-063008 |
| 2024-05-03 | 08:10 ET | [10-Q](/filings/0001821825-24-000056.md) | Quarterly report, period 2024-03-31 | 0001821825-24-000056 |
| 2024-05-02 | 07:43 ET | [8-K](/filings/0001104659-24-056017.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-056017 |
| 2024-04-25 | 16:38 ET | [DEF 14A](/filings/0001193125-24-114048.md) | Proxy statement, period 2024-06-04 | 0001193125-24-114048 |
| 2024-02-26 | 08:10 ET | [10-K](/filings/0001628280-24-006733.md) | Annual report, period 2023-12-31 | 0001628280-24-006733 |
| 2024-02-15 | 07:48 ET | [8-K](/filings/0001104659-24-024358.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-024358 |
| 2023-12-05 | 16:31 ET | [8-K](/filings/0001104659-23-123628.md) | 5.02 Departure or appointment of officers or directors | 0001104659-23-123628 |
| 2023-11-03 | 07:52 ET | [10-Q](/filings/0001821825-23-000013.md) | Quarterly report, period 2023-09-30 | 0001821825-23-000013 |

Page 1 of 2. [Older](/companies/ogn/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 31, 2026, 03:06 ET. No prices; not investment advice.